Abstract
There is a well-documented gap between research and practice in many areas of behavioral medicine. This gap is due in part to limitations in the capacity of the research database to address questions that are of central concern to clinicians, administrative decision makers, and policymakers. Thus, there has been a call for “practical clinical trials” that compare clinically viable alternative interventions and assess multiple outcomes important for clinical and policy decisions in diverse patient populations and settings. Such trials offer great potential, and they raise interesting challenges regarding optimal research design and source of funding. We discuss issues related to practical clinical trials in behavioral medicine, propose a need for practical behavioral trials (PBTs), and describe design features that will facilitate clinical and policy decision making. This type of PBT can help to close the gap between research and practice and advance the field of evidence-based behavioral medicine. We discuss potential challenges and objections to PBTs and conclude by providing recommendations for the design, conduct, reporting, and review of practical trials.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
McGlynn EA, Asch SM, Adams J, et al.: The quality of health care delivered to adults in the United States.New England Journal of Medicine. 2003,348:2635–2645.
Institute of Medicine, Committee on Quality of Health Care in America:Crossing the Quality Chasm: A New Health System For the 21st Century. Washington, DC: National Academy Press, 2001.
Davidson KW, Trudeau KJ, Ockene JK, Orleans CT, Kaplan RM: A primer on current evidence-based review systems and their implications for behavioral medicine.Annals of Behavioral Medicine. 2004,28:226–238.
Spring B, Pagoto S, Kaufmann PG, et al.: Invitation to a dialogue between researchers and clinicians about evidence-based behavioral medicine.Annals of Behavioral Medicine. 2005,30:125–137.
Shadish WR, Cook TD, Campbell DT:Experimental and Quasi-Experimental Design for Generalized Causal Inference. Boston: Houghton Mifflin, 2002.
Stirman SW, DeRubeis RJ, Crits-Christoph P, Rothman A: Can the randomized controlled trial literature generalize to nonrandomized patients?Journal of Consulting and Clinical Psychology. 2005,73:127–135.
Blair E: Gold is not always good enough: The shortcomings of randomization when evaluating interventions in small heterogeneous samples.Journal of Clinical Epidemiology. 2004,57:1219–1222.
Brouwers MC, Johnston ME, Charette ML, et al.: Evaluating the role of quality assessment of primary studies in systematic review of cancer practice guidelines.BMC Medical Research Methodology. 2005,5:8.
Parker G: Evaluating treatments for the mood disorders: Time for the evidence to get real.Australia New Zealand Journal of Psychiatry. 2004,38:408–414.
Flay BR: Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs.Preventive Medicine. 1986,15:451–474.
Glasgow RE, Lichtenstein E, Marcus AC: Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy to effectiveness transition.American Journal of Public Health. 2003,93:1261–1267.
Glasgow RE, Klesges LM, Dzewaltowski DA, Bull SS, Estabrooks P: The future of health behavior change research: What is needed to improve translation of research into health promotion practice?Annals of Behavioral Medicine. 2004,27:3–12.
Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy.Journal of the American Medical Association. 2003,290:1624–1632.
Coyne JC, Palmer SC, Shapiro PJ: Prescribing antidepressants to advanced cancer patients with mild depressive symptoms is not justified.Journal of Clinical Oncology. 2004,22:205–206.
Fisch MJ, Loehrer PJ, Kirsteller J, et al.: Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group.Journal of Clinical Oncology. 2003,21:1937–1943.
Schwartz D, Lellouch J: Explanatory and pragmatic attitudes in therapeutical trials.Journal of Chronic Disease. 1967,20:637.
Vallve C: A critical review of the pragmatic clinical trial.Medicina Clinica. 2003,121:384–388.
Secker-Walker RH, Holland RR, Lloyd CM, Pelkey D, Flynn BS: Cost effectiveness of a community based research project to help women quit smoking.Tobacco Control. 2005,14:37–42.
Epping-Jordan JE: Research to practice: International dissemination of evidence-based behavioral medicine.Annals of Behavioral Medicine. 2004,28:81–87.
Bellg AJ, Borrelli B, Resnick B, et al.: Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the Behavior Change Consortium.Health Psychology. 2004,23:443–451.
Basch CE, Sliepcevich EM, Gold RS: Avoiding Type in errors in health education program evaluations.Health Education Quarterly. 1985,12:315–331.
Rotheram-Borus MJ, Flannery ND: Interventions that are CURRES: Cost-effective, useful, realistic, robust, evolving, and sustainable. In Rehmschmidt H, Belfer ML, Goodyer I (eds),Facilitating Pathways: Care, Treatment, and Prevention in Child and Adolescent Health. New York: Springer, 2004, 235–244.
Rogers EM:Diffusion of Innovations (5th Ed.). New York: Free Press, 2003.
Cronbach LH, Glesser GC, Nanda H, Rajaratnam N:The Dependability of Behavioral Measurements: Theory of Generalizability for Scores and Profiles. New York: Wiley, 1972.
Meenan RT, Stevens VJ, Hornbrook MC, et al.: Cost-effectiveness of a hospital-based smoking cessation intervention.Medical Care. 1998,36:670–678.
Glasgow RE, Ory MG, Klesges LM, et al.: Practical and relevant measures of health behavior for primary care settings.Annals of Family Medicine. 2005,3:73–81.
Kaplan RM: Quality of life, resource allocation, and the U.S. health-care crisis. In Dimsdale JE, Baum A (eds),Quality of Life in Behavioral Medicine Research. Mahwah, NJ: Lawrence Erlbaum Associates, Inc., 1995, 3–30.
Kaplan RM: The significance of quality of life in health care.Quality of Life Research. 2003,12:3–16.
Glasgow RE: Evaluation of theory-based interventions: The RE-AIM model. In Glanz K, Lewis FM, Rimer BK (eds),Health Behavior and Health Education (3rd Ed.). San Francisco: Wiley, 2002, 531–544.
Klesges LM, Estabrooks PA, Glasgow RE, Dzewaltowski D:Beginning with the application in mind: Designing and planning health behavior change interventions to enhance dissemination.Annals of Behavioral Medicine. 2005,29:66–75.
Croyle, R. [Personal communication]. 2003.
Agency for Healthcare Research and Quality:Evidence-Based Practice. Retrieved December 20, 2005, from http://www. ahcpr.gov/clinic/epcix.htm.2001
D’ Agostino Sr. RB, Massaro JM, Sullivan IM: Non-inferiority trials: Design concepts and issues-The encounters of academic consultants in statistics.Statistics in Medicine. 2003,22:169–186.
Is that it, then, for blockbuster drugs? [Editorial].The Lancet. 2004,364:1100.
Schillinger D, Grumbach K, Piette JD, et al.: Association of health literacy with diabetes outcomes.Journal of the American Medical Association. 2002,288:475–482.
Glasgow RE, Magid DJ, Beck A, Ritzwoller D, Estabrooks PA: Practical clinical trials for translating research to practice: Design and measurement recommendations.Medical Care. 2005,43:551–557.
Nutting PA, Beasley JW, Werner JJ: Practice-based research networks answer primary care questions.Journal of the American Medical Association. 1999,281:686–689.
King M, Nazareth I, Lampe F, et al.: Impact of participant and physician intervention preferences on randomized trials: A systematic review.Journal of the American Medical Association. 2005,293:1089–1099.
Rokke PD, Scogin F: Depression treatment preferences in younger and older adults.Journal of Clinical Geropsychology. 1995,1:243–257.
Chilvers C, Dewey M, Fielding K, et al.: Antidepressant drugs and generic counselling for treatment of major depression in primary care: Randomised trial with patient preference arms.British Medical Journal. 2001,322:772–775.
Guthrie E: Psychotherapy for patients with complex disorders and chronic symptoms.British Journal of Psychiatry. 2000,177:131–137.
Bradley C: Clinical trials-Time for a paradigm shift?Diabetic Medicine. 1988,5:107–109.
Williams JW, Katon W, Lin EH, et al.: The effectiveness of depression care management on diabetes-related outcomes in older patients.Annals of Internal Medicine. 2004,140:1015–1024.
Loisel P, Durand MJ, Diallo B, et al.: From evidence to community practice in work rehabilitation: The Quebec experience.Clinical Journal of Pain. 2003,19:105–113.
Loisel P, Abenhaim L, Durand P, et al.: A population-based, randomized clinical trial on back pain management.Spine. 1997,22:2911–2918.
Loisel P, Lemarie J, Poitras S, et al.: Cost-benefit and cost-effectiveness analysis of a disability prevention model for back pain management.Occupational and Environmental Medicine. 2002,59:807–815.
Ockene JK, Ma Y, Zapka JG, et al.: Spontaneous cessation of smoking and alcohol use among low-income pregnant women.American Journal of Preventive Medicine. 2002,23:150–159.
Pbert L, Ockene JK, Zapka J, et al.: A community health center smoking-cessation intervention for pregnant and postpartum women.American Journal of Preventive Medicine. 2004,26:377–385.
Fiore M, Bailey W, Cohen S, et al.:Smoking Cessation: Clinical Practice. Guideline No. 18, AHCPR No. 96–0692. Rockville, MD: U.S. Department of Public Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996.
Glasgow RE, Nutting PA, King DK, et al.: A practical randomized trial to improve diabetes care.Journal of General Internal Medicine. 2004,19:1167–1174.
Green LW: From research to “best practices” in other settings and populations.American Journal of Health Behavior. 2001,25:165–178.
Leung MW, Yen IH, Minkler M: Community-based participatory research: A promising approach for increasing epidemiol-ogy’s relevance in the 21 st century.International Journal of Epidemiology. 2004,33:499–506.
Green LW,OttosonJM:From efficacy to effectiveness to community and back: Evidence-basedpractice vs. practice-based medicine. “From Clinical Trials to Community: The Science of Translating Diabetes and Obesity Research.” Washington, DC: 2004.
Gold MR, Siegel JE, Russell LB, Weinstein MC:Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 2003.
Lamm RD:The Brave New World of Health Care (1st Ed.) Golden, CO: Fulcrum, 2004.
Des Jarlais DC, Lyles C, Crepaz N, TREND Group: Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TREND statement.American Journal of Public Health. 2004,94:361–366.
Best A, Hiatt RA, Cameron R, Rimer BK, Abrams DB: The evolution of cancer control research: An international perspective from Canada and the United States.Cancer Epidemiology, Biomarkers and Prevention. 2003,12:705–712.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is a product of the Evidence-Based Behavioral Committee of the Society of Behavioral Medicine (SBM; see http://www.sbm.org/ ebbm/index.html). Appreciation is expressed to Drs. Michael Goldstein and Evelyn Whitlock and to Kimberlee Trudeau, M.A. for their helpful comments on an earlier version of this article.
About this article
Cite this article
Glasgow, R.E., Davidson, K.W., Dobkin, P.L. et al. Practical behavioral trials to advance evidence-based behavioral medicine. ann. behav. med. 31, 5–13 (2006). https://doi.org/10.1207/s15324796abm3101_3
Issue Date:
DOI: https://doi.org/10.1207/s15324796abm3101_3